Sara-Bay Financial’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-17
Closed -$5.18M 80
2021
Q2
$5.18M Buy
+17
New +$5.18M 1.95% 14